T. Schilling
Impact in
-
- Metal complexes synthesis and properties
-
- Organometallic Complex Synthesis and Catalysis
- Synthetic Organic Chemistry Methods
- Ferrocene Chemistry and Applications
Papers in
- Oncology 5
- Cancer Treatment and Pharmacology 5
- Peptidase Inhibition and Analysis 1
-
- Cancer therapeutics and mechanisms 3
- Plant-derived Lignans Synthesis and Bioactivity 1
- Co-authors
- Axel‐R. Hanauske (5 shared papers)Manfred Heim (1 shared paper)Hermann Dietzfelbinger (1 shared paper)G Niebch (1 shared paper)Adnan Kastrati (1 shared paper)Julinda Mehilli (1 shared paper)Franz–Josef Neumann (1 shared paper)Albert Schömig (1 shared paper)
In The Last Decade
T. Schilling
8 papers receiving 323 citations
Peers
Comparison fields: 5 of 67
- Oncology 109
- Organic Chemistry 97
- Surgery 120
- Cardiology and Cardiovascular Medicine 47
- Pulmonary and Respiratory Medicine 67
Countries citing papers authored by T. Schilling
This map shows the geographic impact of T. Schilling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T. Schilling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T. Schilling more than expected).
Fields of papers citing papers by T. Schilling
This network shows the impact of papers produced by T. Schilling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T. Schilling. The network helps show where T. Schilling may publish in the future.
Co-authors
The 25 scholars most cited alongside T. Schilling, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2000 | 150 | |
| 2 | 1995 | 125 | |
| 3 | 1996 | 23 | |
| 4 | 1996 | 17 | |
| 5 | Clinical phase I study of paclitaxel followed by cisplatin in advanced head and neck squamous cell carcinoma. | 1995 | 11 |
| 6 | 1996 | 8 | |
| 7 | 1990 | 3 | |
| 8 | 1995 | 1 | |
| 9 | 2009 | 0 |
About T. Schilling
T. Schilling is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Immunology and Organic Chemistry, having authored 9 papers that have together received 338 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (5 papers), Cancer therapeutics and mechanisms (3 papers), Brain Metastases and Treatment (2 papers), Plant-derived Lignans Synthesis and Bioactivity (1 paper), Neuroendocrine Tumor Research Advances (1 paper), T-cell and B-cell Immunology (1 paper), Renal Transplantation Outcomes and Treatments (1 paper) and Peptidase Inhibition and Analysis (1 paper). The work is most often cited by research in Oncology (109 citations), Organic Chemistry (97 citations), Surgery (120 citations), Cardiology and Cardiovascular Medicine (47 citations) and Pulmonary and Respiratory Medicine (67 citations). T. Schilling has collaborated with scholars based in Germany, Italy and France. Frequent co-authors include Axel‐R. Hanauske, Manfred Heim, Hermann Dietzfelbinger, G Niebch, Adnan Kastrati, Julinda Mehilli, Franz–Josef Neumann, Albert Schömig, Jürgen Pache and Claus Schmitt. Their work appears in journals such as Investigational New Drugs, Circulation, Cancer Chemotherapy and Pharmacology, Oncology and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.